- Conditions
- Age-Related Lung Function Decline
- Interventions
- Fisetin, Placebo
- Drug
- Lead sponsor
- Cedars-Sinai Medical Center
- Other
- Eligibility
- 60 Years and older
- Enrollment
- 40 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Los Angeles, California
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–7
of 7
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Cellular Senescence
- Interventions
- Fisetin (daily dosing), Fisetin (bolus dosing)
- Drug
- Lead sponsor
- Steadman Philippon Research Institute
- Other
- Eligibility
- 55 Years and older
- Enrollment
- 82 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2024
- U.S. locations
- 1
- States / cities
- Vail, Colorado
- Conditions
- Healthy
- Interventions
- Dasatinib, Quercetin, Fisetin
- Drug
- Lead sponsor
- Sundeep Khosla, M.D.
- Other
- Eligibility
- 60 Years and older · Female only
- Enrollment
- 74 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2023
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
- Conditions
- Aging, Endothelial Dysfunction, Arterial Stiffness
- Interventions
- Fisetin, Placebo
- Dietary Supplement · Other
- Lead sponsor
- University of Colorado, Boulder
- Other
- Eligibility
- 65 Years and older
- Enrollment
- 70 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2027
- U.S. locations
- 1
- States / cities
- Boulder, Colorado
- Conditions
- Peripheral Arterial Disease, Aging, Peripheral Vascular Diseases, Walking, Difficulty, Claudication
- Interventions
- Fisetin, Placebo
- Drug
- Lead sponsor
- Northwestern University
- Other
- Eligibility
- 50 Years and older
- Enrollment
- 34 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Aging, Endothelial Dysfunction, Cellular Senescence
- Interventions
- Fisetin, Placebo
- Dietary Supplement · Other
- Lead sponsor
- University of Colorado, Boulder
- Other
- Eligibility
- 65 Years and older
- Enrollment
- 136 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2031
- U.S. locations
- 1
- States / cities
- Boulder, Colorado
- Conditions
- Fatigue
- Interventions
- Fisetin followed by Placebo, Placebo followed by Fisetin
- Drug
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Eligibility
- 65 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Winston-Salem, North Carolina